(Press-News.org) A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation), caused by herpes simplex virus (HSV) does not improve long-term outcomes overall, although early use may lead to better recovery, and the treatment is safe for patients in whom encephalitis is suspected.
The DexEnceph study, led by researchers at The Pandemic Institute, the University of Liverpool, and Walton Centre NHS Foundation Trust in partnership with Encephalitis International and research teams around the country, provides the most definitive evidence so far on whether corticosteroids should be used alongside antiviral drug aciclovir for this severe, potentially life changing brain infection.
HSV encephalitis is the most common sporadic viral encephalitis worldwide. Although aciclovir has transformed survival since the 1970s, many survivors are left with long-term cognitive difficulties, especially memory problems.
The DexEnceph study was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a partnership between the National Institute for Health and Care Research (NIHR) and the UKRI Medical Research Council (MRC), and the trial results are published today (21 January 2026) in the Lancet Neurology.
No overall benefit but earlier treatment may improve outcomes
The multi-centre, randomised, observer blind phase 3 trial enrolled 94 patients across 53 NHS hospitals. Participants received either dexamethasone plus aciclovir or aciclovir alone. The primary outcome, verbal memory at 26 weeks, assessed using the Wechsler Memory Scale, showed no significant difference overall between the two groups.
Although dexamethasone did not improve overall outcomes, an exploratory analysis showed that when steroids were given earlier in the course of illness, patients tended to do better. The trial also demonstrated that dexamethasone is safe for patients with HSV encephalitis.
Corticosteroids are already used in other inflammatory brain diseases, such as autoimmune encephalitis. Evidence that dexamethasone is safe in HSV encephalitis suggests it could be considered early in all patients with suspected encephalitis, before the cause is confirmed.
Professor Tom Solomon CBE, Chief Investigator of DexEnceph and Director of The Pandemic Institute, said: “For decades people have wondered whether corticosteroids would improve the outcome of herpes simplex virus encephalitis, or perhaps make things worse because of their immunosuppressive effects. Increasingly, when patients present with encephalitis, clinicians want to give corticosteroids in case it is an autoimmune encephalitis, but until they have ruled out herpes simplex virus encephalitis they have not felt it was safe to do so.
“This study shows that if you suspect a patient has encephalitis which might be autoimmune or could be HSV, it is safe to give steroids. The fact that early corticosteroid use seems to be associated with improved outcome may well encourage doctors to do this as soon as they see the patient.
“This trial has been a labour of love. We are deeply grateful to the clinicians across the country who contributed patients, and to the patients and their families who took part. The European guidelines on encephalitis are being revised and we expect they will support earlier use of corticosteroids in patients with suspected encephalitis.”
Dr Ava Easton, Chief Executive of Encephalitis International, said: “People living with the consequences of encephalitis urgently need better treatments. This landmark trial shows what works and what does not. We are proud to have supported this effort and to see a question that has puzzled clinicians for decades finally answered.”
Dr Mark Ellul, Clinical Lecturer at University of Liverpool and Consultant Neurologist said: “For clinicians seeing acutely unwell patients, HSV encephalitis is one of the most devastating neurological emergencies we face. DexEnceph addresses a long-standing area of uncertainty in day-to-day practice, providing evidence to guide treatment in the crucial first days of illness. Just as importantly, this trial shows that it is possible to deliver high-quality randomised studies in acute, life-threatening neurological diseases through national collaboration.
For patients and families affected by HSV encephalitis, this represents a meaningful step towards improving outcomes and standardising care based on evidence rather than assumption.”
Ends
Notes to editors
Post-embargo link to article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00454-5/fulltext
END
Major clinical trial provides definitive evidence of impacts of steroid treatment on severe brain infection
2026-01-22
ELSE PRESS RELEASES FROM THIS DATE:
Low vitamin D levels shown to raise risk of hospitalization with potentially fatal respiratory tract infections by 33%
2026-01-22
Severe vitamin D deficiency is associated with a higher rate of hospitalisation for respiratory tract infections such as bronchitis and pneumonia, according to a new study led by the University of Surrey. Scientists found that those with a severe deficiency (below 15 nnmol/L) were 33 per cent more likely to be admitted to hospital for treatment than those with sufficient levels of vitamin D (at least 75 nmol/L).
In the largest study of its kind, analysing NHS data from the UK Biobank, researchers from Surrey, in collaboration with the University of Reading ...
Diagnoses of major conditions failing to recover since the pandemic
2026-01-22
There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis.
Depression is the most severely impacted, with almost a third fewer diagnoses than expected compared with pre-pandemic trends.
The King’s College London study is the first to evaluate whether diagnosis rates have recovered after emerging from the pandemic. Published today in the British Medical Journal (BMJ), it uses anonymised data from over 29 million people in England.
The pandemic had an unprecedented impact on healthcare systems around the world, leading to abrupt decreases ...
Scientists solve 66 million-year-old mystery of how Earth’s greenhouse age ended
2026-01-22
A 66 million-year-old mystery behind how our planet transformed from a tropical greenhouse to the ice-capped world of today has been unravelled by scientists.
Their new study has revealed that Earth’s massive drop in temperature after the dinosaurs went extinct could have been caused by a large decrease in calcium levels in the ocean.
An international team of experts led by the University of Southampton discovered that concentrations of calcium in the sea dropped by more than half across the last 66 million years.
The ...
Red light therapy shows promise for protecting football players’ brains
2026-01-21
Key points:
Red light therapy is an emerging therapy which shines near-infrared light into the brain through the skull, aiming to reduce inflammation.
A preliminary study with 26 football players suggests that red light therapy could prevent brain inflammation caused by repetitive impacts.
IMPACT: If larger studies confirm the results, red light therapy could help protect people who experience frequent head impacts, like soldiers and athletes, from long-term health consequences.
Punch-drunk syndrome, boxer’s madness, chronic traumatic encephalopathy (CTE). The name has changed over the years, but the cause is clear: repeated impacts can affect long-term brain health, with symptoms ...
Trees — not grass and other greenery — associated with lower heart disease risk in cities
2026-01-21
A multi-institutional study led by the University of California, Davis, finds that living in urban areas with a higher percentage of visible trees is associated with a 4% decrease in cardiovascular disease. By comparison, living in urban areas with a higher percentage of grass was associated with a 6% increase in cardiovascular disease. Likewise, a higher rate of other types of green space, like bushes or shrubs, was associated with a 3% increase in cardiovascular disease.
The new research was published in Environmental Epidemiology.
“Our ...
Chemical Insights scientist receives Achievement Award from the Society of Toxicology
2026-01-21
ATLANTA (Jan. 20, 2026) – UL Research Institutes’ Chemical Insights scientist Katie Paul Friedman, Ph.D. received the prestigious 2026 Achievement Award from the Society of Toxicology (SOT). SOT recognized Dr. Paul Friedman for her leadership in computational toxicology and her contributions to new approach methodologies (NAMs) that are transforming chemical safety assessment. Dr. Paul Friedman, Director of the Center for Informatics and Screening at Chemical Insights, was recognized for exemplifying scientific excellence and service through her innovative research, vision on addressing regulatory needs with NAMs, and dedication ...
Breakthrough organic crystalline material repairs itself in extreme cold temperatures, unlocking new possibilities for space and deep-sea technologies
2026-01-21
A research team, led by Professor of Chemistry at NYU Abu Dhabi Panče Naumov, in collaboration with a research team led by Professor Hongyu Zhang at Jilin University, China, has discovered a new type of organic crystal that can repair itself after being damaged at extremely low temperatures. This breakthrough could pave the way for the next generation of durable, lightweight materials designed to perform in some of the harshest environments on Earth and beyond.
The material, which is one of the newly researched materials known as smart molecular crystals whose discovery was pioneered by Naumov’s group, can restore its structure even ...
Scientists discover novel immune ‘traffic controller’ hijacked by virus
2026-01-21
In a major scientific breakthrough, researchers from Monash University and the Lions Eye Institute have discovered a tissue protein that acts as a central ‘traffic controller’ for immune cells and can be hijacked by a virus to weaken immune responses.
Published today in Nature, the study discovered a key mechanism that controls how immune cells coordinate their responses, and how a common virus can sabotage it.
The research reveals that a molecule called CD44 centrally controls the network of support cells that guide immune system function.
Within this network of support cells, stromal cells help immune cells move efficiently and exchange the information needed ...
When tropical oceans were oxygen oases
2026-01-21
The tropical oceans that once served as oxygen-rich havens for Earth's earliest complex life have become the planet's largest marine dead zones. The dramatic reversal occurred hundreds of millions of years ago and researchers are now beginning to better understand its timing.
A new study led by former Syracuse University doctoral student Ruliang He and co-authored by his advisor, Earth and environmental sciences Professor Zunli Lu, reveals that Earth's ancient tropical oceans were ...
Positive interactions dominate among marine microbes, six-year study reveals
2026-01-21
A six-year analysis of marine microbes in coastal California waters has overturned long-held assumptions about how the ocean's smallest organisms interact.
Researchers at UC San Diego’s Scripps Institution of Oceanography found that marine microbes interact in ways that benefit one another more often than they eat each other or compete. The team also found that periods of elevated ocean temperatures, usually times of stress for these microbes because of a dearth of nutrients, actually resulted in even more of these positive interactions.
The study was published Jan. 21 in the ISME Journal: Multidisciplinary Journal of Microbial ...